Serum Institute seeks emergency use authorisation for its rBCG tuberculosis vaccine
The EUA application was submitted on March 22 by Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII). India's TB immunisation programme currently offers BCG vaccination at birth or as early as possible till one year of age.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Emergency Medicine | Government | India Health | Pharmaceuticals | Tuberculosis | Tuberculosis (BCG) Vaccine | Vaccines